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Abstract: This study reported the volatile profile, the antimicrobial activity and the synergistic poten-
tial of essential oil (EO) from the Moroccan endemic Thymus atlanticus (Ball) Roussine, in combination
with the antibiotics ciprofloxacin and fluconazole for the first time, to the best of our knowledge.
The EO chemical composition was determined by gas chromatography coupled to mass spectrometry
(GC-MS) analysis and the antimicrobial activity assessed by the disc diffusion method against three
Gram positive (Bacillus subtilis, Micrococcus luteus, Staphylococcus aureus) and three Gram-negative
bacteria (Pseudomonas aeruginosa, Escherichia coli and one clinical isolate, Klebsiella pneumonia). The an-
tifungal activity was evaluated in four pathogenic yeasts (Candida albicans, C. glabrata, C. krusei
and C. parapsilosis). The minimum inhibition concentration (MIC) and the synergistic effect with
ciprofloxacin and fluconazole were determined by the two-fold dilution technique and checkerboard
test, respectively. Twenty-one constituents were identified by GC-MS in the EO, including carvacrol
(21.62%) and borneol (21.13%) as the major components. The EO exhibited a significant antimicro-
bial activity with inhibition zones ranging from 0.7 mm to 22 mm for P. aeruginosa and B. subtilis,
respectively, and MIC values varying from 0.56 mg/mL to 4.47 mg/mL. The fractional inhibitory
concentration index (FICI) values ranged from 0.25 to 0.50 for bacteria and from 0.25 to 0.28 for yeasts.
The maximum synergistic effect was observed for K. pneumonia with a 256-fold gain of antibiotic
MIC. Our results have suggested that EO from T. atlanticus may be used alone or in association with
antibiotics as a new potential alternative to prevent and control the emergence of resistant microbial
strains both in the medical field and in the food industry.
Keywords: thyme; Moroccan endemic plant; essential oil; antimicrobial activity; synergy; antibi-
otic resistance
1. Introduction
Morocco is an important reservoir of biodiversity and Mediterranean speciation with
an important flora of around 3913 taxa, including 1298 subspecies in 981 genera and
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155 families. This Moroccan plant biodiversity is characterized by a high percentage of
endemic species (22%), comprising 878 endemic taxa with 599 taxa at the species level [1].
The genus Thymus, belonging to the Lamiaceae family, is widely distributed in Morocco
with 11 endemic species, including Thymus atlanticus (Ball) Roussine, locally known as
“Azukni”. This thyme species is characterized by very small white or pale pink flowers with
revolute leaves or subplanes, glabrescent and in the form of a condensed carpet. It is the
smallest of the Moroccan thymes, and very polymorphic depending on altitude and ecology,
growing between 1700 to 3400 m [2]. For a long time, thyme has been commonly used in
traditional Moroccan medicine to treat many chronic diseases, especially those related to
the digestive system and skin lesions infected with eczema or pathogenic fungi such as
Trichophyton rubrum [3,4]. Moreover, some studies have reported that a T. atlanticus aqueous
extract from leaves exhibits relevant anti-inflammatory and antioxidant activities due to
its high content in total phenolic compounds [5]. In addition, Khouya et al. [6] showed
that the aqueous polyphenol-rich extract of this plant inhibited the blood coagulation ex
vivo and in vivo. However, to the best of our knowledge, the antimicrobial activity of
T. atlanticus has never been evaluated.
Previous reports showed that Moroccan endemic thymes exhibited important biologi-
cal properties, including antifungal, antimicrobial, antiviral and antioxidant activities [7–9].
Furthermore, it was demonstrated that extracts from other Moroccan endemic thymes,
such as T. riatarum, T. maroccanus and T. broussonetii, exhibited a high antimicrobial efficacy
in combination with standard antibiotics as new efflux pump inhibitors or as membrane
permeabilizers [7,10]. In general, the combination of antimicrobial drugs with natural
products from medicinal plant characterized by a multicomponent chemical composition
and multitarget mechanism of action provides many benefits, such as the decrease of the
toxic effects of the combined active ingredients. This new and safe alternative can solve the
problem of antimicrobial resistance that has become a serious public health concern with
economic, social and medical implications, especially in the case of multidrug-resistant
microbes and resulting infections. In this context, this study aimed to evaluate, for the first
time, the antimicrobial and antifungal activities of the essential oil obtained from aerial
organs of the Moroccan endemic T. atlanticus, along with its synergistic effect with standard
antimicrobials (ciprofloxacin and fluconazole).
2. Results and Discussion
The steam distillation of T. atlanticus aerial parts provided a yellow oil with a yield
of 1.41%, based on dry plant material (v/w). The obtained yield was similar to the values
reported for some thyme species, although it was different when compared with others.
For example, Fadli et al. [7] reported that the yield of the EOs obtained from T. maroccanus
and T. broussonetii were 1.38% and 1.2%, respectively. In another work, the T. riatarum yield
was 0.26% [10]. Mahboubi et al. [11] obtained yields of Iranian thymes ranging from 2% to
2.2% for T. vulgaris and T. daenensis, and from 0.68% to 1.1% for T. kotschyanus, T. fedtschenkoi
and T. pubescens.
The GC-MS analysis of the T. atlanticus EO revealed the presence of 21 volatile com-
pounds (Table 1 and Figure 1) representing 97.44% of total oil. The major components were
carvacrol (21.62%) and borneol (21.13%), followed by γ-terpinene (9.98%), o-cymene (8.14%)
and camphene (7.28%). Monoterpenes (88.91%) were the most represented compounds.
Quantitative differences in the chemical profile were noted in comparison with Fadli et al.,
(2014) in which borneol (41.67%) was the most abundant component of the T. riatarum EO,
followed by α-terpineol (8.65%), whereas carvacrol (0.75%) was present in small amounts.
Fadli et al. [7] also reported a different composition, with carvacrol (76.35% and 39.77%)
and borneol (0.41% and 12.03%) as the main constituents of EO from Moroccan endemic
thymes (T. maroccanus and T. broussonetii, respectively). A recent study revealed differences
in the chemical composition of T. vulgaris EO, where thymol (55.3%) was identified as the
major metabolite [12]. Furthermore, Mahboubi et al. [11] demonstrated that EOs extracted
from the Iranian chemotypes T. fedtschenkoi and T. pubescens were rich in thymol (50.6%
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and 26.6%, respectively) and carvacrol (6.6% and 27%, respectively). Based on the obtained
results, the variation between the chemical composition of our samples and those deter-
mined for other thyme species can depend on several factors such as the geographical
location, climate, plant material and the season of the material collection [13].
Table 1. Components of essential oil distilled from the leaves of Moroccan endemic T. atlanticus.
Entries in bold are major constituents.


























RI: Retention index measured relative to n-alkanes (C-9 to C-24) on a non-polar TG-5MS column.
1 
Figure 1. GC-MS chromatogram of T. atlanticus essential oil. (1): Camphene; (2): γ-Terpinene; (3): Endo-borneol; (4): Carvacrol.
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The disk diffusion assay showed that the EO had a broad-spectrum antimicrobial activ-
ity, with inhibition zones (IZ) ranging from 7 mm (in P. aeruginosa) to 22 mm (in B. subtilis)
(Table 2). The EO showed a powerful inhibitory activity against B. subtilis (IZ = 22 mm) and
both Gram-negative bacteria, namely E. coli (IZ = 18 mm) and K. pneumoniae (IZ = 16 mm)
(Table 2). The EO also exhibited a high antifungal potential against the pathogenic yeasts
C. albicans (IZ = 15 mm), C. glabrata (IZ = 18 mm), C. krusei (IZ = 20 mm) and C. parapsilosis
(IZ = 12 mm) (Table 2). The MIC values showed that the EO inhibited all the tested mi-
croorganisms at a concentration of 0.56 mg/mL, except for S. aureus and P. aeruginosa,
which were inhibited at 1.12 mg/mL and 4.47 mg/mL, respectively (Table 2). Remark-
ably, the Gram-negative bacterium P. aeruginosa seemed to be the least sensitive. Overall,
the EO exhibited a significant antimicrobial activity, probably due to its chemical profile
rich in carvacrol and borneol. The oxygenated monoterpene cavacrol is a well-known
and efficient antimicrobial agent that can damage the cell membrane or other cytoplasmic
targets passing through the altered phospholipid bilayer [14–16]. Similarly, the bicyclic
monoterpene borneol is also a powerful and broad-spectrum antimicrobial agent able to
alter the membrane structural and functional integrity [17]. In addition, other volatile
compounds present in lower percentages can also contribute to the biological activity of
the EO, including γ-terpinene, linalool and thymol [18–20]. Concerning the resistance of
P. aeruginosa, it is well known that a multidrug-resistant bacterium uses many different
mechanisms to counteract the antimicrobial drugs [21]. In general, the major mechanisms
that P. aeruginosa has developed were the lower outer membrane permeability, as intrinsic
resistance, and the biofilm formation, as adaptive resistance, that serves as a diffusion
barrier to limit the access of bioactive substances into the bacterial cells [22].
Table 2. Inhibition zone (IZ) diameters and minimum inhibitory concentrations (MIC) of the essential oil (EO) extracted










Staphylococcus aureus 13.0 1.12 26.0 0.01 - -
Micrococcus luteus 12.0 0.56 27.0 0.03 - -
Bacillus subtilis 22.0 0.56 35.0 0.01 - -
Gram-negative bacteria
Escherichia coli 18.0 0.56 12.0 0.06 - -
Klebsiella pneumoniae 16.0 0.56 09.0 01.0 - -
Pseudomonas aeruginosa 07.0 4.47 08.0 0.25 - -
Yeasts
Candida albicans 15.0 0.56 - - 20.0 1
Candida glabrata 18.0 0.56 - - 13.0 1
Candida krusei 20.0 0.56 - - 24.0 1
Candida parapsilosis 12.0 0.56 - - 28.2 1
IZ: inhibition zones (mm). MIC: minimum inhibitory concentration (mg/mL).
As reported in Tables 3 and 4, a total synergism was observed in the 10 tested combi-
nations of T. atlanticus EO and both antibiotics (ciprofloxacin and fluconazole). The best
synergistic effect was recorded in K. pneumoniae and C. parapsilosis, with FICI values of 0.25.
The gain of antibiotic MIC in the presence of EO ranged from 4- to 256-fold. The highest
reduction of fluconazole MIC was observed against C. parapsilosis (256-fold), whereas the
three other yeast strains had a 32-fold gain. For Gram-positive bacteria, a high decrease was
recorded for K. pneumoniae, E. coli and M. luteus, from 256- to 64-fold. Our results showed
that the T. atlanticus EO enhanced the antimicrobial activity of the reference antibiotic
drugs. Previous studies reported the interaction between antimicrobial agents and other
Moroccan thyme EOs. For example, Fadli et al. [10] demonstrated that the addition of
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T. riatarum EO against E. coli AG100 reduced the chloramphenicol MIC from 8 mg/mL to
2 mg/mL. Similarly, Saad et al. [9] showed that the synergistic effect of T. maroccanus and
T. broussonetii EOs, in combination with amphotericin B and fluconazole, resulted in FICI
values of 0.49, 0.27, 0.37 and 0.3, respectively, and decreased the antibiotic MICs with more
than an 8-fold gain.
Table 3. Synergistic interaction between T. atlanticus essential oil (EO) and ciprofloxacin against resistant bacteria.





FIC FICI Gain FIC FICI Gain FIC FICI Gain FIC FICI Gain FIC FICI Gain FIC FICI Gain
EO 0.25 - - 0.25 - - 0.25 - - 0.25 - - 0.25 - - 0.25 - -
Ciprofloxacin 0.02 0.27 a 64 0.25 0.50 a 4 0.06 0.31 a 16 0.02 0.27 a 64 0.25 0.50 a 4 0.00 0.25 a 256
FIC: fractional inhibitory concentration. FICI: fractional inhibitor concentration index. FIC of oil = MIC of EO in combination with
antibiotic/MIC of EO alone. FIC of antibiotic = MIC of antibiotic in combination with EO/MIC of antibiotic alone. FIC index = FIC of EO +
FIC of antibiotic. a Total synergism.
Table 4. Synergistic interaction between T. atlanticus essential oil (EO) and fluconazole against clinical pathogenic yeasts.
Candida albicans Candida glabrata Candida krusei Candida parapsilosis
FIC FICI Gain FIC FICI Gain FIC FICI Gain FIC FICI Gain
EO 0.25 - - 0.25 - - 0.25 - - 0.25 - -
Fluconazole 0.03 0.28 a 32 0.03 0.28 a 32 0.03 0.28 a 32 0.00 0.25 a 256
FIC: fractional inhibitory concentration. FICI: fractional inhibitor concentration index. FIC of oil = MIC of EO in combination with
antibiotic/MIC of EO alone. FIC of antibiotic = MIC of antibiotic in combination with EO/MIC of antibiotic alone. FIC index = FIC of EO +
FIC of antibiotic. a Total synergism.
Our results contribute to substantiate the traditional uses of T. atlanticus by the Moroc-
can populations for the treatment of skin infections caused by different types of microor-
ganisms, thus suggesting that its EO could be further investigated as a natural source of
adjuvant agents to be used in combination with conventional antibiotics to reduce the risk
of selecting antibiotic resistant microbial strains.
3. Materials and Methods
3.1. Plant Material and Essential Oil (EO) Distillation
The aerial parts of T. atlanticus were collected by M. Brahim Oummad in September
2019 from the Imider municipality in the Tinghir province of the Drâa-Tafilalet adminis-
trative region of Morocco (31.352509◦ N, 5.832241◦ W). Samples were placed at 25 ◦C in
shade to air-dry for one week and their voucher specimens (THAL-46) were conserved at
the laboratory of Microbial Biotechnologies, Agrosciences and Environment, Faculty of
Sciences Semlalia, Cadi Ayyad University, Marrakech, Morocco. The identification of this
thyme species was carried out by Nafis Ahmed, based on the dichotomous keys of Moroc-
can flora. Dried leaves were subjected to steam distillation for 3 h and the preparation of
the essential oil was performed three times (3 × 50 g). Then, the recovered EO was stored
at 4 ◦C in darkness. The yield percentage was calculated as volume (in mL) of EO by 100 g
of dried plant material.
3.2. Gas Chromatography-Mass Spectrometry (GC-MS) Analysis
The GC-MS system was used to qualitatively and quantitatively characterize the
chemical composition of T. atlanticus EO, as previously described [23]. Gas chromatographic
coupled to mass spectrometric (GC-MS) analysis was performed on a 1300 GAZ gas
chromatograph equipped with a TG-5MS column (30 m length; 0.25 mm i.d.; 0.25 µm
film thickness) and coupled to mass selective detector “ISQ Single Quadrupole Mass
spectrometer” (70 eV). The analytical conditions were: carrier gas, helium; injection volume
was 1 µL; injector temperature 260 ◦C, temperature program was 1 min at 100 ◦C, ramped
from 100 ◦C to 260 ◦C at 4 ◦C/min and 10 min at 246 ◦C. The individual identification
of each volatile compound was based on the comparison of the obtained mass spectra
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with NIST and Wiley library reference data and the Kovats retention indices (RI) with a
reference library of a series of C9 to C24 n-alkanes.
3.3. Microorganisms and Culture Conditions
The antibacterial activity of the EO was evaluated against three Gram-positive bacteria,
namely Bacillus subtilis (ATCC 9524), Micrococcus luteus (ATCC 10240), Staphylococcus aureus
(CCMM B3) and three Gram-negative bacteria, i.e., Pseudomonas aeruginosa (DSM 50090),
Escherichia coli (ATCC 8739) and clinically isolated Klebsiella pneumoniae. In addition, the an-
tifungal activity was assessed using the following four pathogenic yeasts: Candida albicans
(CCMM-L4), C. glabrata (CCMM-L7), C. krusei (CCMM-L10) and C. parapsilosis (CCMM-
L18) [24]. The bacterial and yeast species were cultivated for previous use on Muller Hinton
agar (at 37 ◦C) and Sabouraud dextrose agar (at 28–30 ◦C) plates, respectively.
3.4. Minimum Inhibitory Concentration (MIC) and Synergistic Effect Determination
MIC was determined using the two-fold dilution method, as previously described [25].
Briefly, Each microwell was contained 100 µL of oil dilution and 100 µL of cell suspension
prepared by dilution (1/100) an overnight culture in MHB and Sabouraud media for
bacteria (106 CFU/mL) and yeasts (1–2 × 103 cells/mL), respectively. The MIC value
corresponded to the well with the lowest concentration of EO and without any visible
microbial growth. The ciprofloxacin and fluconazol MIC values were also determined.
The synergistic effect between the EO and ciprofloxacin and fluconazole was evaluated
by determining the antibiotic MIC in presence of the EO at a sub-inhibitory concentration
(MIC/4), and the antibiotic MICs were performed using the checkerboard method as
previously reported [26]. Briefly, 50 µL of the EO (at MIC/4) and each serial two-fold
dilution of antibiotics were inoculated with 100 µL of a cell suspension of each strain
(approximately 106 UFC/mL). MIC values were defined as the lowest concentration of
antibiotics, in combination with the EO at MIC/4, inhibiting the visible growth of tested
microorganisms. All the tests were performed in triplicate.
To determine the combined effect of antimicrobials and the EO, we calculated the
fractional inhibitory concentration index (FICI) which is the most frequently used to define
or to describe drug interactions. FICI values were defined according to Odds, 2003 [27]:
no interaction (FICI between 0.5 and 4), synergy (FICI ≤ 0.5) and antagonism (FICI ≥ 4).
The MIC gain of antibiotics was calculated as the antibiotic MIC alone divided by the MIC
of antibiotic combined with the EO.
4. Conclusions
The T. atlanticus EO was characterized by 21 volatile constituents, and carvacrol
(21.62%) and borneol (21.13%) were found to be the most abundant. The EO exhibited a sig-
nificant antimicrobial activity, with MIC values varying from 0.56 mg/mL to 4.47 mg/mL.
Moreover, EO showed a total synergistic effect with both antibiotics towards all tested
strains and the highest gain in term of antibiotic MIC value was reported against K. pneu-
monia, with a 256-fold gain. Our results suggested that the EO extracted from T. atlanticus
should be further explored with the aim of investigating its potential use as a tool for the
management of multi-drug resistant microorganisms.
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